All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Biogen Idec Inc. shares (NASDAQ:BIIB) sunk 5.4 percent Wednesday to $309.07 despite third quarter net earnings of $857 million, or $3.62 per diluted share, up 76 percent from last year's third quarter.
